Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton Saute

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Israel Medical Association Journal : IMAJ|June 21, 2002
The effect of donor age on survival after lung transplantationGabriel Izbicki, David Shitrit, Dan Aravot, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Recurrence of pulmonary veno-occlusive disease after heart-lung transplantationGabriel Izbicki, David Shitrit, Itzhak Schechtman, et al.
Oncology|April 23, 2018
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung CancerAaron M Allen, Tzippy Shochat, Dov Flex, et al.
Thoracic Cancer|September 22, 2018
Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesotheliomaMichael Simon, Tzippy Shochat, Nir Peled, et al.
Clinical Transplantation|September 9, 2017
Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional statusHagit Levine, Dario Prais, Yael Raviv, et al.
Radiation Oncology (London, England)|April 27, 2018
Stereotactic body radiotherapy for central lung tumors, yes we can!Yasmin Korzets Ceder, Eyal Fenig, Aron Popvtzer, et al.
Journal of Cardiothoracic Surgery|January 11, 2019
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
Journal of Cardiothoracic Surgery|February 14, 2019
Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
American Journal of Industrial Medicine|February 2, 2017
Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosisDror Rosengarten, Benjamin D Fox, Elizabeth Fireman, et al.
Therapeutic Advances in Respiratory Disease|January 5, 2024
Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort studyOfir Deri, David Ovadia, Ella Huszti, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Israel Medical Association Journal : IMAJ|June 21, 2002
The effect of donor age on survival after lung transplantationGabriel Izbicki, David Shitrit, Dan Aravot, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2005
Recurrence of pulmonary veno-occlusive disease after heart-lung transplantationGabriel Izbicki, David Shitrit, Itzhak Schechtman, et al.
Oncology|April 23, 2018
High-Dose Radiotherapy as Neoadjuvant Treatment in Non-Small-Cell Lung CancerAaron M Allen, Tzippy Shochat, Dov Flex, et al.
Thoracic Cancer|September 22, 2018
Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesotheliomaMichael Simon, Tzippy Shochat, Nir Peled, et al.
Clinical Transplantation|September 9, 2017
Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional statusHagit Levine, Dario Prais, Yael Raviv, et al.
Radiation Oncology (London, England)|April 27, 2018
Stereotactic body radiotherapy for central lung tumors, yes we can!Yasmin Korzets Ceder, Eyal Fenig, Aron Popvtzer, et al.
Journal of Cardiothoracic Surgery|January 11, 2019
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
Journal of Cardiothoracic Surgery|February 14, 2019
Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexityDan Aravot, Yaron D Barac, Efrat Krutzwald-Josefson, et al.
American Journal of Industrial Medicine|February 2, 2017
Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosisDror Rosengarten, Benjamin D Fox, Elizabeth Fireman, et al.
Therapeutic Advances in Respiratory Disease|January 5, 2024
Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort studyOfir Deri, David Ovadia, Ella Huszti, et al.
Pageof 6